The Zafirlukast Tablets, cataloged under National Stock Number 6505-01-440-2989, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 1 specification, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-440-2989 |
| Item Name | Zafirlukast Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| General Characteristics Item Description | 20 MG; 60 TABLETS PER BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| 96-0751 | 5/1 Secondary reference U.S. Government activity |
| ACCOLATE | 5/9 Secondary reference Astrazeneca Lp |
| NDC00310-0402-60 | 3/9 Design control — primary reference Astrazeneca Lp |
NSN 6505-01-440-2989 is a Zafirlukast Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-440-2989: General Characteristics Item Description: 20 MG; 60 TABLETS PER BOTTLE; Part Name Assigned by Controlling Agency: ACCOLATE. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.